Edwyn
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $5,632 | $4,863 | $4,030 | $4,030 | $4,101 |
| Gross Profit | $3,796 | $2,997 | $2,072 | $2,228 | $2,118 |
| Operating Income | $2,480 | $1,640 | $668 | $883 | $714 |
| Net Income | $1,872 | $1,302 | $456 | $790 | $566 |
Over the five-year period, HOLOGIC, INC.’s financials show notable volatility in revenue and profitability. In 2021, the company reported its highest revenue at 5,632.3 million USD with a strong gross profit of 3,795.8 million USD and robust operating and net income figures (2,480.3 and 1,871.5 million USD, respectively). However, a marked decline occurred in 2022 as revenue dropped about 14% to 4,862.8 million USD, accompanied by a more than 20% decrease in gross profit to 2,997.4 million USD. The downturn worsened in 2023 when revenue fell nearly 17% further to 4,030.4 million USD and gross profit plunged by roughly 31% year-over-year to 2,071.5 million USD. Operating income and net income experienced even sharper declines with a drop of approximately 59% and 65% from 2022 to 2023, respectively. These significant year-over-year swings suggest potential challenges in pricing, cost management, or market demand during this period. In 2024, there was a modest stabilization, as revenue held steady at about 4,030 million USD while gross profit rebounded to 2,227.8 million USD, and operating income improved to 882.6 million USD. Nonetheless, in 2025, revenue saw a slight uptick to 4,100.5 million USD, yet profitability metrics, including operating and net income, fell again. These mixed results indicate that while HOLOGIC managed a brief recovery, underlying pressures persisted. Overall, the company’s financial health appears challenged by declining margins and fluctuating performance. This volatility, given HOLOGIC’s role in the competitive healthcare and diagnostics industry, suggests that sustaining profitability may require strategic operational adjustments and tighter cost controls.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.